Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Wolff (Borstel, Germany), N. El-Merhie (Borstel, Germany), S. Bartel (Borstel, Germany), H. Fehrenbach (Borstel, Germany), S. Reuter (Borstel, Germany), S. Krauss-Etschmann (Borstel, Germany). Murine model for investigating virus-induced exacerbations of COPD-related inflammation – preclinical biomarker validation. 4974

Member's Comments

No comment yet.

Related content which might interest you: Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Development of a novel prediction model for acute asthma exacerbation Source: International Congress 2018 – Asthma management Year: 2018 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Progress in modelling acute lung injury in a pre-clinical mouse model Source: Eur Respir J 2012; 39: 1062-1063 Year: 2012 An experimental model of rhinovirus-induced COPD exacerbation Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Longitudinal imaging characterisation of a model of chronic allergic lung inflammation in mice Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 Role of CD163 in human fatal asthma and murine asthma model. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Murine models of asthma Source: Guideline 2003 Year: 2003 IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "in vitro" models Source: Annual Congress 2011 - T-cell subsets Year: 2011 Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018